Patents / Publications

Patents / Publications

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.
Date :2018-04-13 09:43 Hit :7,133

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.

Chungyong Han, Su-Jung Sim, Seon-Hee Kim, Rohit Singh, Sunhee Hwang, Yu I. Kim, Sang H. Park, Kwang H. Kim, Don G. Lee, Ho S. Oh, Q1 Sangeun Lee, Young H. Kim, Beom K. Choi & Byoung S. Kwon.

 

 

Abstract

Chimeric antigen receptor (CAR) T cell therapy is an effective method for treating specific cancers. CARs are normally designed to recognize antigens, which are highly expressed on malignant cells but not on T cells. However, when T cells are engineered with CARs that recognize antigens expressed on the T cell surface, CAR T cells exhibit effector function on other T cells, which results in fratricide, or killing of neighboring T cells. Here, using human leukocyte antigen-DR (HLA-DR)-targeted CAR T cells, we show that weak affinity between CAR and HLA-DR reduces fratricide and induces sustained CAR downregulation, which consequently tunes the avidity of CAR T cells, leading to desensitization. We further demonstrate that desensitized CAR T cells selectively kill Epstein-Barr virus-transformed B cells with enhanced HLA-DR expression, while sparing normal B cells. Our study supports an avidity-tuning strategy that permits sensing of antigen levels by CAR T cells.

 

Nat Commun. 2018 Feb 1;9(1):468. doi: 10.1038/s41467-018-02912-x.




Link (Click to move)